Matthew J. D'Onofrio

This profile gathers the share dealings of Matthew J. D'Onofrio in Evoke Pharma Inc. We count 13 filings; the first trade dates from 27 February 2015 and the latest from 16 December 2025.

No open-market purchase appears, only 2 sales worth €110k. The rest of the record consists of 3 share grants and 1 option exercise.

The latest filing, published on 17 December 2025, reports a transaction in Evoke Pharma Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.